Revealing item in The Times about (unfortunately behind a pay-wall) AstraZeneca’s supposed philanthropy in selling its vaccine at cost price;
The vaccine is being sold on a non-profit basis during the pandemic but the business is entitled to royalty and milestone payments, which could become lucrative if the virus remains active in the population over the long term.
Which no doubt is what they are banking on.
No comments:
Post a Comment